139 related articles for article (PubMed ID: 37387973)
1. Retracted: Correlations between Clinical Characteristics and Prognosis in Patients with Grade II Glioma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9765049. PubMed ID: 37387973
[TBL] [Abstract][Full Text] [Related]
2. Retracted: Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9807106. PubMed ID: 38094830
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Analysis of Clinical Characteristics and Risk Factors of Postoperative Recurrence and Malignant Transformation of Low-Grade Glioma.
Oncology JO
J Oncol; 2023; 2023():9832716. PubMed ID: 37476550
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Knockdown of lncRNA
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9859158. PubMed ID: 37501828
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Screening and Identification of Key Biomarkers in Lower Grade Glioma via Bioinformatical Analysis.
And Biomechanics AB
Appl Bionics Biomech; 2023; 2023():9829723. PubMed ID: 38075158
[TBL] [Abstract][Full Text] [Related]
6. Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma.
Markers D
Dis Markers; 2023; 2023():9781753. PubMed ID: 37502593
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma.
International BR
Biomed Res Int; 2023; 2023():9869137. PubMed ID: 38188730
[TBL] [Abstract][Full Text] [Related]
8. [Retracted] 14‑3‑3β exerts glioma‑promoting effects and is associated with malignant progression and poor prognosis in patients with glioma.
Liu L; Liu Z; Wang H; Chen L; Ruan F; Zhang J; Hu Y; Luo H; Wen S
Exp Ther Med; 2024 Mar; 27(3):93. PubMed ID: 38313580
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Correlations of Ezrin Expression with Pathological Characteristics and Prognosis of Osteosarcoma: A Meta-Analysis.
Journal TSW
ScientificWorldJournal; 2022; 2022():9860781. PubMed ID: 36324370
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence-Free Survival for High-Grade Glioma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9761763. PubMed ID: 37503375
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9761231. PubMed ID: 37388089
[TBL] [Abstract][Full Text] [Related]
12. Retracted: KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9856509. PubMed ID: 37810558
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Correlations between Intestinal Microbiota and Clinical Characteristics in Colorectal Adenoma/Carcinoma.
International BR
Biomed Res Int; 2023; 2023():9810254. PubMed ID: 38188806
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9837208. PubMed ID: 37476733
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9853753. PubMed ID: 37387913
[TBL] [Abstract][Full Text] [Related]
16. Retracted: A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes.
International BR
Biomed Res Int; 2024; 2024():9854370. PubMed ID: 38550201
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9806931. PubMed ID: 37564810
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Application of Deep Learning Technology in Glioma.
Engineering JOH
J Healthc Eng; 2022; 2022():9764617. PubMed ID: 36619245
[TBL] [Abstract][Full Text] [Related]
19. Retracted: CRNDE/ETS1/GPR17 Facilitates the Proliferation, Migration, and Invasion of Glioma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9814841. PubMed ID: 37811263
[TBL] [Abstract][Full Text] [Related]
20. Retracted: The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9801756. PubMed ID: 37593684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
